Zobrazeno 1 - 10
of 113
pro vyhledávání: '"S Soderberg"'
Publikováno v:
European Heart Journal. 43
Background A recent post-hoc analysis of the GRIPHON randomised controlled trial [1] showed that selexipag reduces the risk of a morbidity/mortality event versus placebo in pulmonary arterial hypertension (PAH) patients, irrespective of comorbidity b
Autor:
S Cederstrom, P Lundman, J Alfredsson, E Hagstrom, A Ravn-Fischer, S Soderberg, T Yndigegn, P Tornvall, T Jernberg
Publikováno v:
European Heart Journal. 43
Background Despite abundant knowledge about the relationship between inflammation and coronary artery disease (CAD), it is still unknown whether high sensitivity C-reactive protein (hsCRP) is associated with coronary atherosclerosis in the general po
Autor:
N Arnold, C Blaum, A Gossling, T Zeller, A Linneberg, S Soderberg, L Iacoviello, S Sans, V Leoni, F Kee, V Salomaa, K Kuulasmaa, S Blankenberg, W Koenig, C Waldeyer
Publikováno v:
European Heart Journal. 43
Background Lipoprotein(a) (Lp(a)) represents a unique proatherogenic lipoprotein with potent pro-thrombotic and pro-inflammatory properties. Recent studies demonstrated that Lp(a)-associated risk for cardiovascular disease (CVD) was significantly inc
Publikováno v:
European Heart Journal. 43
Background The 2021 European Society of Cardiology (ESC) prevention guidelines recommend the Systemic Coronary Risk Estimation 2 algorithm (SCORE2) to estimate the 10-year risk of cardiovascular disease (CVD) events to guide pharmacological treatment
Publikováno v:
European Heart Journal. 43
Background Treatment patterns for patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) are currently not well described. Purpose To use real-world data from the EXPOSURE study to describe clinical character
Publikováno v:
European Heart Journal. 43
Background Angina pectoris (AP) is a common clinical presentation with low association to significant coronary artery disease (CAD) in selected cohorts, though yet associated with an elevated risk of major cardiovascular adverse events. Current knowl
Publikováno v:
European Heart Journal. 43
Introduction Acute pulmonary embolism (PE), a common disease with substantial morbidity and mortality. Many previous studies have focused on the short-term consequences after an acute PE, but less attention has been directed to the long-term effects
Autor:
B Toprak, S Brandt, J Brederecke, F Ojeda, S Soderberg, A Linneberg, W Koenig, M L Lochen, S Blankenberg, K Kuulasmaa, V Salomaa, L Iacoviello, T Niiranen, T Zeller, R Schnabel
Publikováno v:
European Heart Journal. 43
Background Atrial fibrillation (AF) remains a major health issue in Europe and worldwide. Risk prediction is crucial to identify at-risk individuals and prevent subsequent complications of AF such as stroke and heart failure. Biomarker-enriched, pers
Autor:
S. Kowlessur, J. Tuomilehto, H. Taki, U. Nilsson, J. Heecharan, N. Joonas, B. Ori, J. Shaw, G. Alberti, P. Zimmet, S. Soderberg
Publikováno v:
Diabetes Research and Clinical Practice. 197:110456
Autor:
Janet S. Soderberg, Sara Stull, Rachel J. Han, Kevin Cummings, Deborah McCutchen, Gail E. Joseph
Publikováno v:
Early Education and Development. 31:764-777
This study explores the inter-rater reliability of WaKIDS, Washington State’s kindergarten entry assessment (KEA). Specifically, we analyze (1) the extent to which teachers’ assessments are in agre...